Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2020

Nov 25, 2020

31708_dirs_2020-11-25_fad84dd7-5693-4c5b-8407-4147b70c6fc4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2020-11-24

Reporting Person: Kamke Trent G (Senior V. P., Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-24 Common Stock S 18609 $39.9891 Disposed 2838 Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $39.45 to $40.53. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.